The Board proposes the development of rule amendments to address the requirements of Section 456.44, F.S., with regard to the prescribing of controlled substances for the treatment of acute pain.

 

DEPARTMENT OF HEALTH

Board of Medicine

RULE NO.:RULE TITLE:

64B8-9.013Standards for the Use of Controlled Substances for the Treatment of Pain

PURPOSE AND EFFECT: The Board proposes the development of rule amendments to address the requirements of Section 456.44, F.S., with regard to the prescribing of controlled substances for the treatment of acute pain.

SUBJECT AREA TO BE ADDRESSED: The prescribing of controlled substances for the treatment of acute pain.

RULEMAKING AUTHORITY: 456.44(4), 458.309(1), 458.331(1)(v) FS.

LAW IMPLEMENTED: 456.44, 458.326, 458.331(1)(g), (t), (v) FS.

IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Claudia Kemp, J.D., Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253.

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS AVAILABLE AT NO CHARGE FROM THE CONTACT PERSON LISTED ABOVE.